Table 1

Clinical characteristics of aSAH patients with preventive and rescue intrathecal therapy

PREVENTIVERESCUEP value
No of patients, n (%)62 (73.8)22 (26.1)
Type of intervention for cisternal therapy
 STX-VCS, n (%)51 (82)22 (100)
 CVC, n (%)11 (18)
Time between aSAH onset and intervention, mean, hours (range)53 (4–108)161 (24–272)<0.0001
Female, number (%)43 (69%)17 (77)0.59
Age, median, years (IQR)61 (52–66)52 (45–63)0.033
WFNS grade, n (%)
 12 (3)7 (32)<0.0001
 24 (6)3 (14)
 34 (6)4 (18)
 412 (19)1 (5)
 543 (69)7 (32)
Hijdra score
 Ventricles6.2 (4.1)3.3 (4.3)0.0049
 Cisterns20.1 (8.0)13.1 (7.2)0.0003
 Total26.3 (8.6)16.5 (7.3)0.0001
Location of ruptured aneurysm, n (%)
 MCA13 (21)11 (50)0.0055
 ACA34 (55)3 (14)
 ICA7 (11)5 (23)
 PCA8 (13)3 (14)
Aneurysm treatment, n (%)
 Clip24 (38)14 (64)0.051
 Coil38 (62)8 (36)
Prespecified DCI-risk by de Rooij score, % (SD)47.5% (±11.4)37.7% (±15.1)0.003
  • p-values of parameters reaching statistically significant differences between groups are marked in bold font

  • ACA, anterior cerebral artery; aSAH, aneurysmal subarachnoid haemorrhage; CVC, cisterno-ventriculostomy catheter; DCI, delayed cerebral infarction; ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior circulation arteries; STX-VCS, stereotactic catheter ventriculocisternostomy; WFNS, World Federation of Neurosurgical Societies.